Trial intelligence / Profile preview

Bridging Study Comparing Two Sci-B-Vac Batches in Healthy Adults

NCT04531098Phase 3Completed

Sponsor
VBI Vaccines Inc.
Start
Mar 2006
Primary completion
Dec 2008
Modality
Split/Subunit Vaccines, Recombinant Protein Vaccines
Countries
1
01

Overview

A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by VBI Vaccines Inc.. Started Mar 2006; status: completed.

02

Drugs

Hepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT04531098.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04531098.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call